Status:
COMPLETED
Clinicopathologic Characteristics, Progression, and Prognostic Analysis of IPNB
Lead Sponsor:
The First Hospital of Jilin University
Conditions:
Bile Duct Neoplasms Malignant
Eligibility:
All Genders
Brief Summary
The main aim of this observational study is to understand the clinicopathological and prognostic information of IPNB, a rare tumor. The participants have already received treatment during their previo...
Eligibility Criteria
Inclusion
- IPNB with or without malignant transformation was confirmed by pathological examination
Exclusion
- missing other essential clinical data
- coexisting malignant tumors of other digestive system organs
Key Trial Info
Start Date :
December 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2025
Estimated Enrollment :
118 Patients enrolled
Trial Details
Trial ID
NCT06887023
Start Date
December 1 2024
End Date
February 1 2025
Last Update
March 20 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
the First Hospital of Jilin University
Changchun, Jililn, China, 130000